Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03733249
Title Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Recruitment Enrolling by invitation
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications

hematologic cancer

Therapies

Rimiducid + Rivogenlecleucel

Age Groups: child | adult
Covered Countries ITA


No variant requirements are available.